A TOP2A -derived cancer panel drives cancer progression in papillary renal cell carcinoma

Oncology Letters
Mushi YeJianjun Liu

Abstract

The aim of the present study was to investigate the function of the DNA topoisomerase IIα (TOP2A) gene and its associated genes in the progression of papillary renal cell carcinoma (PRCC). Online cancer databases, including cBioportal, Oncomine, OncoLnc and Search Tool for the Retrieval of Interacting Genes/Proteins were used to analyze the TOP2A gene expression profile, function and regulation network in PRCC. The genes that were significantly co-expressed or mutually exclusively expressed with TOP2A were identified. The genes co-expressed with TOP2A were defined as a 'TOP2A-cancer panel', which cooperatively promotes PRCC progression. This gene panel performed well in predicting the prognosis of PRCC. In addition, the TOP2A-cancer panel significantly affected the outcome of PRCC compared with clear cell renal cell carcinoma (CCRCC). The protein-protein interaction network of all genes associated with TOP2A was also generated. This interaction network may provide foundation for the additional investigation of TOP2A. Integrative understating of the TOP2A-cancer panel may result in a novel avenue for treatment intervention in PRCC.

References

Mar 11, 1999·Current Opinion in Genetics & Development·R D Kolodner, G T Marsischky
Sep 30, 2000·Kidney International·L V IvanovaD Proppe
Aug 15, 2002·The Journal of Cell Biology·Thomas A KuferErich A Nigg
Apr 8, 2004·Neoplasia : an International Journal for Oncology Research·Daniel R RhodesArul M Chinnaiyan
Jun 3, 2004·Nature Reviews. Molecular Cell Biology·Francis A BarrErich A Nigg
Aug 4, 2004·Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology·Stephen S TaylorAndrew J Holland
Aug 24, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jon JonesTowia A Libermann
Nov 26, 2005·The Journal of Clinical Investigation·Jens DannullJohannes Vieweg
Nov 4, 2006·Cancer·Ellen A RonnenRobert J Motzer
Jan 12, 2007·The New England Journal of Medicine·Bernard EscudierUNKNOWN TARGET Study Group
Jan 23, 2009·Cell Cycle·Kyung Uk HongJoobae Park
Mar 31, 2012·Archives of Pathology & Laboratory Medicine·Hillary RossPedram Argani
Jul 25, 2012·Nature Reviews. Cancer·Oliver Rath, Frank Kozielski
Feb 13, 2013·Journal of Translational Medicine·Marina França de ResendeRafael Malagoli Rocha
Apr 4, 2013·Science Signaling·Jianjiong GaoNikolaus Schultz
Jan 7, 2014·Current Drug Targets·Xuning Emily GuoWen-Hwa Lee
Apr 26, 2014·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Holly LaDucaElizabeth Chao
Sep 10, 2014·Cancers·Genevieve HousmanSibaji Sarkar
Sep 1, 2015·Lancet·Umberto Capitanio, Francesco Montorsi
Nov 6, 2015·Nature Reviews. Cancer·Adam A FriedmanKeith T Flaherty
Nov 21, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Fuminori ItoTokiko Nakai
Sep 23, 2016·The New England Journal of Medicine·Robert L GrossmanLouis M Staudt
Apr 26, 2017·Frontiers in Endocrinology·Qingyu ZhangLeo Tsz On Lee
Jul 25, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian ShuchNeeraj Agarwal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.